Cargando…
Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
BACKGROUND AND OBJECTIVES: Janus kinase (JAK) inhibitors are emerging as a therapeutic option for alopecia areata. The risk of potential adverse events is currently debated. In particular, several safety data for JAK inhibitors are extrapolated from a single study in elderly patients with rheumatoid...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155665/ https://www.ncbi.nlm.nih.gov/pubmed/37138134 http://dx.doi.org/10.1007/s40261-023-01260-z |